1. Home
  2. TMDX vs PECO Comparison

TMDX vs PECO Comparison

Compare TMDX & PECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • PECO
  • Stock Information
  • Founded
  • TMDX 1998
  • PECO 1991
  • Country
  • TMDX United States
  • PECO United States
  • Employees
  • TMDX N/A
  • PECO N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PECO Real Estate Investment Trusts
  • Sector
  • TMDX Health Care
  • PECO Real Estate
  • Exchange
  • TMDX Nasdaq
  • PECO Nasdaq
  • Market Cap
  • TMDX 3.9B
  • PECO 4.3B
  • IPO Year
  • TMDX 2019
  • PECO 2021
  • Fundamental
  • Price
  • TMDX $114.30
  • PECO $34.72
  • Analyst Decision
  • TMDX Buy
  • PECO Buy
  • Analyst Count
  • TMDX 11
  • PECO 7
  • Target Price
  • TMDX $130.73
  • PECO $38.00
  • AVG Volume (30 Days)
  • TMDX 1.0M
  • PECO 1.0M
  • Earning Date
  • TMDX 10-29-2025
  • PECO 10-23-2025
  • Dividend Yield
  • TMDX N/A
  • PECO 3.62%
  • EPS Growth
  • TMDX 170.70
  • PECO 37.32
  • EPS
  • TMDX 2.54
  • PECO 0.65
  • Revenue
  • TMDX $566,354,000.00
  • PECO $711,781,000.00
  • Revenue This Year
  • TMDX $38.84
  • PECO $9.92
  • Revenue Next Year
  • TMDX $20.46
  • PECO $4.73
  • P/E Ratio
  • TMDX $45.35
  • PECO $53.06
  • Revenue Growth
  • TMDX 41.20
  • PECO 10.73
  • 52 Week Low
  • TMDX $55.00
  • PECO $32.40
  • 52 Week High
  • TMDX $145.50
  • PECO $40.12
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 40.85
  • PECO 57.28
  • Support Level
  • TMDX $115.21
  • PECO $33.10
  • Resistance Level
  • TMDX $125.57
  • PECO $35.16
  • Average True Range (ATR)
  • TMDX 7.65
  • PECO 0.51
  • MACD
  • TMDX -1.72
  • PECO 0.07
  • Stochastic Oscillator
  • TMDX 12.41
  • PECO 79.32

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About PECO Phillips Edison & Company Inc.

Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interests, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on market of expertise designed to optimize property value and consistently deliver a great shopping experience.

Share on Social Networks: